Celgene Reports Third Quarter 2016 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
BTIG Reaffirms Celgene (CELG) at 'Buy'; Q3 Results, Update Bolster Confidence
October 28, 2016 11:30 AM EDTBTIG affirms Celgene Corporation (Nasdaq: CLEG) at Buy with a price target of $138 following Q3 results and update.
The firm commented today: Full-year 2016 EPS guidance moved up +$0.17 at the midpoint, above the +$0.10 3Q16 EPS beat, and highlighted Sales and EPS for... More
